Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ACST Financial Statements and Analysis

NASDAQ : ACST

Acasti Pharma Inc.

$3.37
0.13+4.01%
At Close 4:00 PM
Not Actively Trading
64.19
BESG ScoreESG Rating

ACST FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ACST Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateJun 30, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242023202320232023
periodQ1Q3Q2Q1Q4
revenue0000-32.00K
cost of revenue1.00K3.043M2.092M4.454M14.083M
gross profit-1.00K-3.043M-2.092M-4.454M-14.115M
gross profit ratio0000441.094
research and development expenses2.708M1.443M460.00K1.095M1.64M
general and administrative expenses2.254M1.57M1.589M1.811M2.465M
selling and marketing expenses-1.00K30.00K-43.00K60.00K51.00K
selling general and administrative expenses2.254M1.60M1.546M1.871M2.516M
other expenses-2.254M0009.00K
operating expenses4.962M3.043M2.006M2.969M4.165M
cost and expenses4.963M3.043M4.098M2.969M4.165M
interest income235.00K316.00K212.00K134.00K187.00K
interest expense235.00K316.00K212.00K134.00K67.699M
depreciation and amortization1.00K1.00K2.00K7.00K8.00K
ebitda-4.962M-3.17M-4.098M-1.485M29.749M
ebitda ratio0000-929.656
operating income-4.963M-3.043M-4.098M-4.454M29.741M
operating income ratio0000-929.406
total other income expenses net1.622M128.00K379.00K-1.477M-67.699M
income before tax-3.341M-2.599M-3.719M-4.312M-37.958M
income before tax ratio00001.186K
income tax expense-724.00K-208.00K-446.00K-289.00K-8.871M
net income-2.617M-2.391M-3.719M-4.023M-29.087M
net income ratio0000908.969
eps-0.24-0.21-0.49-0.54-0.79
eps diluted-0.24-0.21-0.49-0.54-0.79
weighted average shs out10.929M11.506M7.553M7.436M36.842M
weighted average shs out dil10.929M11.506M7.553M7.436M36.842M
Graph

ACST Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateJun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
reported currencyUSDUSDUSDUSDUSD
calendar year20242023202320232023
periodQ1Q4Q3Q2Q1
cash and cash equivalents19.394M27.875M18.545M26.991M21.633M
short term investments15.00K15.00K6.569M15.00K15.00K
cash and short term investments19.409M27.89M25.114M27.006M21.648M
net receivables398.00K802.00K959.00K837.00K837.00K
inventory00000
other current assets622.00K598.00K811.00K1.044M1.127M
total current assets20.429M29.29M26.884M28.887M23.612M
property plant equipment net22.999K567.00K35.00K57.00K155.00K
goodwill8.138M8.138M8.138M8.138M8.138M
intangible assets41.128M41.128M41.128M41.128M41.128M
goodwill and intangible assets49.266M49.266M49.266M49.266M49.266M
long term investments00000
tax assets00000
other non current assets1.000000
total non current assets49.289M49.833M49.301M49.323M49.421M
other assets00000
total assets69.718M79.123M76.185M78.21M73.033M
account payables1.549M1.242M913.00K685.00K607.00K
short term debt075.00K24.00K46.00K80.00K
tax payables00000
deferred revenue00-913.00K-685.00K-607.00K
other current liabilities1.051M2.094M1.746M1.351M1.886M
total current liabilities2.60M3.411M1.77M1.397M1.966M
long term debt0410.00K000
deferred revenue non current00000
deferred tax liabilities non current4.79M7.347M6.403M6.611M7.057M
other non current liabilities2.964M03.332M3.457M0
total non current liabilities7.754M7.757M9.735M10.068M7.057M
other liabilities00000
capital lease obligations0485.00K24.00K46.00K80.00K
total liabilities10.354M11.168M11.505M11.465M9.023M
preferred stock00000
common stock261.038M258.294M261.038M261.038M258.294M
retained earnings-213.736M-198.266M-207.953M-205.562M-202.289M
accumulated other comprehensive income loss-6.038M-6.038M-6.038M-6.038M-6.038M
other total stockholders equity18.10M13.965M17.633M17.307M14.043M
total stockholders equity59.364M67.955M64.68M66.745M64.01M
total equity59.364M064.68M66.745M64.01M
total liabilities and stockholders equity69.718M79.123M76.185M78.21M73.033M
minority interest00000
total investments15.00K15.00K6.569M15.00K15.00K
total debt0485.00K24.00K46.00K80.00K
net debt-19.394M-27.39M-18.521M-26.945M-21.553M
Graph

ACST Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateJun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
reported currencyUSDUSDUSDUSDUSD
calendar year20242023202320232023
periodQ1Q4Q3Q2Q1
deferred income tax-724.00K-8.871M-208.00K-446.00K-289.00K
stock based compensation238.00K322.00K326.00K280.00K78.00K
change in working capital900.00K353.00K506.00K-464.00K-2.026M
accounts receivables326.00K0-190.733K23.0035.00K
inventory00000
accounts payables00000
other working capital574.00K0696.733K-464.023K-2.061M
other non cash items-2.204M33.949M-126.00K1.788M13.00K
net cash provided by operating activities-3.596M-3.326M-1.892M-2.113M-6.24M
investments in property plant and equipment0-8.00K000
acquisitions net0-23.00K-977.00110.073K0
purchases of investments-15.00K5.015M-6.554M00
sales maturities of investments05.00M000
other investing activites0-4.992M977.00-73.000
net cash used for investing activites-15.00K4.992M-6.554M110.00K0
debt repayment00000
common stock issued0-304.00K-65.333K7.338M0
common stock repurchased00000
dividends paid00000
other financing activites0304.00K021.00K0
net cash used provided by financing activities00-65.333K7.359M0
effect of forex changes on cash0-32.00K65.333K2.00K-2.00K
net change in cash-3.611M1.634M-8.446M5.358M-6.242M
cash at end of period19.394M27.875M18.545M26.991M21.633M
cash at beginning of period23.005M26.241M26.991M21.633M27.875M
operating cashflow-3.596M-3.326M-1.892M-2.113M-6.24M
capital expenditure0-8.00K000
free cash flow-3.596M-3.334M-1.892M-2.113M-6.24M
Graph

Frequently Asked Questions

How did Acasti Pharma Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ACST generated $0.00 in revenue last quarter, while its costs came in at $1.00K.
Last quarter, how much Gross Profit did Acasti Pharma Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Acasti Pharma Inc. reported a -$1.00K Gross Profit for the quarter ended Jun 30, 2023.
Have ACST's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ACST incurred $4.96M worth of Operating Expenses, while it generated -$4.96M worth of Operating Income.
How much Net Income has ACST posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Acasti Pharma Inc., the company generated -$2.62M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Acasti Pharma Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Acasti Pharma Inc. as of the end of the last quarter was $19.39M.
What are ACST's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ACST had Total Net Receivables of $398.00K.
In terms of Total Assets and Current Assets, where did Acasti Pharma Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ACST were $20.43M, while the Total Assets stand at $69.72M.
As of the last quarter, how much Total Debt did Acasti Pharma Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ACST's debt was $0.00 at the end of the last quarter.
What were ACST's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ACST reported total liabilities of $10.35M.
How much did ACST's Working Capital change over the last quarter?
Working Capital Change for ACST was $900.00K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
ACST generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ACST generated -$3.60M of Cash from Operating Activities during its recently reported quarter.
What was ACST's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ACST reported a -$3.61M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph